Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-06

Clinical Trial Update: A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of a combination of estradiol and progesterone for vasomotor symptoms in menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estradiol and Progesterone combination

Snippet

Sponsor: TherapeuticsMD | Conditions: Menopause | Phase 3 | Status: COMPLETED | Results posted: 2019-05-06